ABSTRACT
) can be accurately estimated from the incremental shuttle walk distance (ISWD) and;
(ii) ESWTs performed at a speed derived using the original method elicited 85% of
Agreement between walks speeds was determined using Bland-Altman analysis.
Results: Twenty-two participants (FEV 1 48±13% predicted, age 66±8 yr) completed the study. 
Conclusions:
Components of the original method for determining the ESWT speed did not hold true in our sample. ESWT speed can be derived by calculating 85% of the peak speed achieved during the ISWT.
INTRODUCTION
The endurance shuttle walk test (ESWT) 1 is an assessment of walking endurance that is appropriate for assessing the response to interventions in people with chronic obstructive pulmonary disease (COPD). 2 Its popularity as an outcome in clinical studies is increasing, largely as a result of its superior responsiveness when compared with other field based walking tests, such as the six-minute walk test (6MWT) 3, 4 and the incremental shuttle walk test (ISWT). 1 The method for calculating the speed for the ESWT, as described in the original publication, 1 involves four components. First, an ISWT is performed and the distance walked (ISWD) is recorded. Second the ISWD is entered into a regression equation to estimate an individual's peak rate of oxygen uptake (
). Third, a value equivalent to 85% of the estimated
calculated. Fourth, a walk speed corresponding to 85% of the estimated
is derived using a published figure that relates walk speed to the rate of oxygen uptake. 1 This four-component process can be time-consuming for clinicians and the reliance on the published figure during the final component may lead to imprecision when determining the speed for this test.
We recently compared the cardiorespiratory responses to the 6MWT, ISWT, ESWT with a rampbased cycle ergometry test. 5 A secondary analysis of these data allowed us to determine the extent to which the components described in the original method for calculating an appropriate speed for the ESWT held true and whether the process for deriving the speed for the ESWT could be simplified. The specific aims for this study were to determine:
can be accurately derived from ISWD.
2. Whether the rate of oxygen uptake during the ESWT was equivalent to 85% of
The agreement between ESWT speeds derived using the original four-component process and that equivalent to 85% of the peak speed achieved during the ISWT.
METHODS
Patients with stable COPD were recruited from referrals to pulmonary rehabilitation programs and respiratory medicine clinics. Individuals were excluded if they had evidence of a co-morbid condition that may have adversely affected their capacity to complete field-based walking tests such as severe lower back pain or required a gait aid or supplemental oxygen during exercise. As the aims of the current study, data were used for the test that yielded the best ISWD and the first of the two ESWTs. The speed for the ESWT was determined according to the method originally described. 1 Standard protocols were used for both tests, 1, 7 and participants were instructed to increase their walking speed when they first lagged behind the pace dictated by the audio-signal. To determine the extent to which the rate of oxygen uptake measured during the ESWT corresponded to 85% of the peak 2 O V  achieved during the ISWT, we compared the peak 2 O V  achieved during the two tests using a paired t-test. Further, the pattern of change in the rate of oxygen uptake between the ISWT and ESWT was compared by; (i) grouping data into deciles of the total test duration using a two-dimensional data transformation (Sigmaplot ® , version 12.0) and, (ii) fitting a curve to the profile of the mean data for each test. Data collected during the 90 second warm-up that preceded the ESWT were excluded from these analyses.
We determined whether the speed equivalent to 85% of the peak speed achieved during the ISWT differed from that derived using the original four-component process using a paired t-test and the methods described by Bland-Altman.
9
Sample size calculations
The results of this study arise from the retrospective analyses of an existing dataset. Therefore, sample size calculations were not undertaken to meet the specific aims of this study.
Nevertheless, our sample size yielded adequate power (α = 0.05, 1-β = 0.8) to detect a difference in speeds for the ESWT (i.e. that equivalent to 85% of the peak speed achieved during the ISWT and that derived using the original four-component process) of 0.17 ± 0.27 km·h -1 (or 2.8 m·min
. This difference is the smallest difference in pre-recorded speeds available for the ESWT.
RESULTS
Characteristics of the 22 participants (14 men) are summarised in Table 1 
Results addressing aim 3
The speed equivalent to 85% of the peak speed achieved during the ISWT was 4.44 ± 0.67 km•h 
DISCUSSION
This study explored whether the peak rate of oxygen uptake ( estimated from the ISWD. Nevertheless, on average, the speed for the ESWT derived using the original four-component process resulted in a desirable duration for time to symptom limitation of between 4 and 7 min. 11 Our data suggest that using 85% of the peak walk speed achieved during the ISWT produced similar speeds for the ESWT when compared with that derived using the original four-component process. These findings indicate that components of the original method described to calculate the speed for the ESWT may not hold true in patients with COPD and are unnecessary when calculating the speed for the ESWT. We propose that the speed for this test can be simply determined by calculating 85% of the peak speed achieved during the ISWT.
When determining the speed for the ESWT, VO 2peak is estimated in order to relate the intensity of the test to an individual's aerobic capacity 1 and to achieve a baseline endurance time within the responsive range. 11 The equation published to estimate as the dependent variable. 8 Our data demonstrated that this equation produced values that were significantly less than those directly measured during the test. The reasons for this do not appear to be related to differences in the samples between the studies. That is, compared with our sample, the participants in the original study had similar disease severity (forced expiratory volume in one second; 1.1 ± 0.4 L vs. 1.4 ± 0.5 L) and functional impairment (ISWD; 343 ± 104 m vs. 375 ± 137 m). 8 Further, both studies used the same ISWT protocol. 8 However, in contrast with our study which measured peak 2 O V  using a portable gas analysis system during the ISWT, the original paper measured the peak 2 O V  during a laboratory-based treadmill test. 8 Compared to ground walking with frequent turns back and forth around a 10 m course, treadmill walking 11 requires less energy and is more efficient. 1 When walking at similar speeds, these differences produced a consistent tendency to walk for longer on a treadmill compared with ground walking. 1 The reduced efficiency associated with ground walking around a 10 m course is likely to have increased the rate of oxygen uptake for any given ISWD when compared with measurements made during treadmill walking. The weight of the portable gas analysis unit worn by the participants in our study would also have contributed a small amount to the higher rate of oxygen uptake. We speculate these to be the reasons why the published regression equation , estimated using the published regression equation, within the first 0.5 min of the ESWT. These data do not suggest that the speed chosen for the ESWT was inappropriate. In fact, the time to symptom limitation measured in our study (378 ± 298 s) is likely to be highly responsive to change, 11, 13 and suggests that the speed was close to 120% of the maximum sustainable walking speed. 13 Rather, these data simply highlight that an ESWT performed at a speed derived using the original fourcomponent process will elicit a Our data demonstrate similarity between the speeds derived for the ESWT using the original four-component process and that calculated to be 85% of the peak speed achieved during the ISWT. Of note, these two methods differed, on average, by 0.15 km•h -1 (i.e. 2.5 m•min -1 ). An increase in walking speed of this magnitude has the potential to reduce the time to symptom limitation by approximately one minute. 13 However, given that performance improves with familiarisation by an average of 50 to 60 sec, 1, 5 any reduction in time to symptom limitation reduction is likely to be offset, at least in part, by repeating the test. This suggests that the speed for the ESWT can be derived by simply calculating 85% of the peak speed achieved during the ISWT rather than completing a more complicated four-component process.
Limitations

13
The main limitation of this study was that we did not measure the time to symptom limitation achieved during the ESWT performed at a speed equivalent to 85% of the peak speed achieved during the ISWT and further research is needed in this area. Notwithstanding this, we estimated the difference in time to symptom limitation during the ESWT performed at this slightly faster speed using our previously published data demonstrating the power-endurance relationship during walking tasks in COPD. 13 As patients who use gait aids and supplemental oxygen were excluded, it is possible that our results do not extend to these sub-groups. Further, as the study sample was characterised by moderate to severe COPD, it is unclear if our results extend to individuals with mild or very severe disease.
Conclusions
In a sample of participants with stable COPD, our data suggest that the regression equation used estimated from the ISWD. Further, speeds equivalent to 85% of the peak walk speed achieved during the ISWT were similar to that derived using the original four-component process. Taken together, these results suggest that components described in the original method for determining the speed for the ESWT did not hold true and are unnecessary. We propose that speeds for the ESWT can be simply derived by calculating 85% of the peak speed achieved during the ISWT. 
